Dr. Kevin M. Holcomb

Dr. Kevin Holcomb guides the Division of Gynecologic Oncology at Northwell Health. Multidisciplinary conferences place radiology, pathology, genetics, and supportive-care experts around a single virtual table so diagnostic images, molecular signatures, and personal goals align before the first incision. Clinic coordinators group laboratory tests, prehabilitation sessions, and anesthesia clearance into a one-day itinerary that spares families repeated travel, and nurse navigators follow with plain-language summaries that explain, for example, why sentinel lymph-node mapping can avoid a full pelvic dissection yet still secure accurate staging. Quality dashboards track voice preservation, transfusion rates, and time to adjuvant therapy; weekly reviews trigger immediate tweaks such as earlier speech-therapy consults or same-day cytology reads. Patients therefore move through a pathway that feels orderly and transparent, confident that each specialist sees the entire picture and remains reachable when questions arise. 

 

Dr. Holcomb’s research focuses on how surgical technique, tumor biology, and health-equity intersect to improve gynecologic-cancer outcomes. His flagship trials evaluate robotic cytoreduction for recurrent ovarian cancer and assess whether fluorescence-guided sentinel mapping can lower lymph-edema without sacrificing oncologic control. Parallel laboratory projects analyze PI3K and MAPK activation in high-grade endometrial carcinoma, testing short-course targeted therapy to shrink tumors before resection. Clinical specimens reach a biobank within minutes, where single-cell sequencing reveals resistant clones that feed the design of adaptive protocols. Outcomes data feed into national registries that compare minimally invasive and open approaches, and his analyses have shaped guidelines recommending laparoscopic staging for selected ovarian germ-cell tumors. This rapid bench-to-bedside loop means discoveries presented at conferences translate into updated consent forms within weeks, giving patients early access to strategies once listed as experimental.

 

Education and outreach amplify Dr. Holcomb’s influence beyond the operating room. He mentors fellows through simulation curricula that pair three-dimensional pelvic models with live commentary on ergonomics and tissue handling, then publishes the resulting performance metrics in open-access forums so programs worldwide can benchmark progress. As a faculty advisor to student diversity initiatives, he partners with public-school teachers to host anatomy workshops that demystify medical careers for under-represented youth. Community webinars delivered in English and Spanish explain early symptoms of ovarian and uterine cancers, telehealth navigation, and the value of genetic testing; recordings stream through regional health-system portals so information reaches households without broadband. Nationally, he co-authors position papers addressing racial disparities in uterine-cancer survival, urging insurers to cover molecular profiling and fertility-sparing surgery regardless of zip code. Podcasts and concise infographic posts keep frontline clinicians current on trial eligibility and enhanced-recovery protocols, reinforcing a cycle where knowledge travels as quickly as science advances.